Sareum shares rise after improved interim results, research progress
Sareum shares rise after improved interim results, research progress
Read moreMon, 15th Aug 2011 11:50
Sareum shares rise after improved interim results, research progress
Read moreIN BRIEF: Sareum Notes Launch Of UK Government's Agile Platform
Read more(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office has now formally approved its patent application, number 16/351,620.
Read moreUK WINNERS & LOSERS SUMMARY: Mitchells & Butlers Down Amid Raise Plan
Read moreSareum Shares Rise On Granting Of Patent For SDC-1802 Inhibitor
Read moreIN BRIEF: Sareum Makes Progress On Potential Covid Treatment Candidate
Read moreSareum Shares Surge 30% After Study Results Support Covid-19 Programme
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreIN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment
Read more(Sharecast News) - Specialist drug development company Sareum Holdings announced on Thursday that the grant offer letter from UK Research and Innovation (UKRI) had now been received and approved.
Read moreUK TRADING UPDATE SUMMARY: Clipper Expects 20% Interim Revenue Climb
Read moreIN BRIEF: Sareum Nets Covid-19 Therapy UK Research Grant
Read moreIN BRIEF: Sareum Loss Narrows On Reduced Administration Expenses
Read moreUK TRADING UPDATE SUMMARY: Motorpoint Predicts Local Lockdowns Bite
Read more(Sharecast News) - Specialist drug development company Sareum announced on Thursday that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent on an invention associated with its proprietary 'SDC-1802 TYK2/JAK1 Kinase Inhibitor Programme'.
Read more